Therefore, hematological and serum biochemistry biomarkers, for instance, neurofilaments, MCP-1, interleukins, and hemoglobin, can be evaluated as possible biomarkers, enabling the early diagnosis and prognosis of ALS [7,8]. The gene discussed is CCL2; the disease is amyotrophic lateral sclerosis.